Limited Liability Company (LLC)
Amorphis Pharma Development
Amorphis Pharma Development Spółka z Ograniczoną Odpowiedzialnością
Limited Liability Company (LLC)
Amorphis Pharma Development Spółka z Ograniczoną Odpowiedzialnością
Amorphis Pharma Development compared with its industry and competitors: revenue, profit and capital percentiles. Regional ranking and position within its PKD class.
Sector benchmark available (PKD 21.10.Z), no company financial data to compare.
Comparison with selected competing entities based on the most important financial indicators from recent years.
Type a name or KRS number to add any company to the chart and table below. Compared: 6 (5 competitors + analysed).
Indicator: Revenue
One chart shows the analysed company alongside selected competitors. The view presents the most important financial indicators from recent years, letting you quickly assess scale, profitability and the company's market position.
A side-by-side comparison of the most important financial data for the analysed company and its peers.
| Company | Revenue▼ | Net profit | EBITDA | Assets | Equity | Net margin | ROE | Liquidity | Years | Latest year | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Amorphis Pharma DevelopmentAnalysed KATOWICE · Farmaceutyka | 64,1 tys. zł | 15,4 tys. zł | 44,6 tys. zł | 1,0 mln zł | 456,1 tys. zł | 23,96% | 3,37% | 50,31 | 2 | 2022 | |
BIOPHARMACOTECH CZĘSTOCHOWA · Farmaceutyka | 18,0 mln zł | 344,0 tys. zł | 1,6 mln zł | 35,3 mln zł | 14,3 mln zł | 1,91% | 2,41% | 1,87 | 4 | 2024 | |
L-AMINO PLUS CZĘSTOCHOWA · Farmaceutyka | 5,2 mln zł | 649,9 tys. zł | 671,0 tys. zł | 3,3 mln zł | 1,5 mln zł | 12,41% | 44,45% | 1,81 | 2 | 2024 | |
HARCIAREK EURODARM POLSKA CZĘSTOCHOWA · Farmaceutyka | 4,6 mln zł | 320,5 tys. zł | 655,4 tys. zł | 13,4 mln zł | 150,1 tys. zł | 6,93% | 213,46% | 1,38 | 4 | 2025 | |
NATUR DAY NAKŁO ŚLĄSKIE · Farmaceutyka | 2,6 mln zł | 338,1 tys. zł | - | 1,4 mln zł | 61,8 tys. zł | 13,21% | 547,15% | - | 7 | 2024 | |
BIOPOLONIA SPÓŁKA Z OGRANICZONĄ ODPOWIE… CZĘSTOCHOWA · Farmaceutyka | 1,2 mln zł | 539,7 tys. zł | 800,5 tys. zł | 11,0 mln zł | 10,4 mln zł | 45,10% | 5,19% | 0,55 | 6 | 2024 |
Each row is a different financial indicator. The arrow and percentage value show how much each competitor exceeds or trails the analysed company.Green means the analysed company leads, red - that it falls behind.
| Indicator | Amorphis Pharma Development 2022 | BIOPHARMACOTECH 2024 | L-AMINO PLUS 2024 | HARCIAREK EURODARM POLSKA 2025 | NATUR DAY 2024 | BIOPOLONIA SPÓŁKA Z OGRANIC… 2024 |
|---|---|---|---|---|---|---|
| Revenue | 64,1 tys. zł | 18,0 mln zł +27964.1% | 5,2 mln zł +8069.2% | 4,6 mln zł +7118.7% | 2,6 mln zł +3891.2% | 1,2 mln zł +1766.7% |
| Net profit | 15,4 tys. zł | 344,0 tys. zł +2139.7% | 649,9 tys. zł +4131.5% | 320,5 tys. zł +1986.7% | 338,1 tys. zł +2101.5% | 539,7 tys. zł +3413.8% |
| EBITDA | 44,6 tys. zł | 1,6 mln zł +3470.9% | 671,0 tys. zł +1406.1% | 655,4 tys. zł +1371.2% | - | 800,5 tys. zł +1696.8% |
| Operating profit | 14,6 tys. zł | 1,3 mln zł +8787.5% | 664,8 tys. zł +4468.9% | 523,7 tys. zł +3499.1% | - | 778,9 tys. zł +5252.8% |
| Assets | 1,0 mln zł | 35,3 mln zł +3266.8% | 3,3 mln zł +215.8% | 13,4 mln zł +1179.2% | 1,4 mln zł +30.8% | 11,0 mln zł +949.7% |
| Equity | 456,1 tys. zł | 14,3 mln zł +3027.5% | 1,5 mln zł +220.5% | 150,1 tys. zł -67.1% | 61,8 tys. zł -86.5% | 10,4 mln zł +2181.6% |
| Net margin | 23,96% | 1,91% -22.0 pp | 12,41% -11.5 pp | 6,93% -17.0 pp | 13,21% -10.7 pp | 45,10% +21.1 pp |
| ROE | 3,37% | 2,41% -1.0 pp | 44,45% +41.1 pp | 213,46% +210.1 pp | 547,15% +543.8 pp | 5,19% +1.8 pp |
| Current ratio | 50,31 | 1,87 -4843.5 pp | 1,81 -4849.9 pp | 1,38 -4892.9 pp | - | 0,55 -4975.3 pp |
Peer entities are picked based on activity profile (PKD), voivodeship, business scale and data availability. You can add your own peers using the search above.
Filter: PKD 21.10.Z, voivodeship śląskie. Data taken from /ranking and /reports.
PKD 21.10.Z - ŚLĄSKIE
Voivodeship
ŚLĄSKIE
17 companies in PKD in this voivodeship
Companies in PKD - voivodeship
17
Companies in PKD - nationwide
105
Voivodeship share of PKD
16.19%
Revenue position
Rank 42 - broader population
Avg. PKD revenue (region)
4.3 M PLN
Median PKD revenue (region)
641.7 K PLN